Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Guanhao BiotechLtd Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Guanhao BiotechLtd has a total shareholder equity of CN¥465.9M and total debt of CN¥68.6M, which brings its debt-to-equity ratio to 14.7%. Its total assets and total liabilities are CN¥694.7M and CN¥228.9M respectively. Guanhao BiotechLtd's EBIT is CN¥25.1M making its interest coverage ratio 419.3. It has cash and short-term investments of CN¥109.7M.
Anahtar bilgiler
14.7%
Borç/özkaynak oranı
CN¥68.57m
Borç
| Faiz karşılama oranı | 419.3x |
| Nakit | CN¥109.74m |
| Eşitlik | CN¥465.90m |
| Toplam yükümlülükler | CN¥228.85m |
| Toplam varlıklar | CN¥694.75m |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Optimistic Investors Push Guanhao Biotech Co.,Ltd. (SZSE:300238) Shares Up 28% But Growth Is Lacking
Sep 02
Guanhao Biotech Co.,Ltd. (SZSE:300238) May Have Run Too Fast Too Soon With Recent 28% Price Plummet
Jun 07Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 26% Share Price Plunge Could Signal Some Risk
Apr 23Guanhao Biotech Co.,Ltd.'s (SZSE:300238) 32% Share Price Surge Not Quite Adding Up
Mar 09Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 300238's short term assets (CN¥265.2M) exceed its short term liabilities (CN¥148.5M).
Uzun Vadeli Yükümlülükler: 300238's short term assets (CN¥265.2M) exceed its long term liabilities (CN¥80.4M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 300238 şirketinin toplam borcundan daha fazla nakdi var.
Borcun Azaltılması: 300238's debt to equity ratio has reduced from 24.6% to 14.7% over the past 5 years.
Borç Kapsamı: 300238's debt is well covered by operating cash flow (78.1%).
Faiz Kapsamı: 300238's interest payments on its debt are well covered by EBIT (419.3x coverage).